Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2022

04.02.2021 | Original Article

Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis

verfasst von: Kana Shiraishi, Shinya Furukawa, Sen Yagi, Kenichirou Mori, Tomoyuki Ninomiya, Keitarou Kawasaki, Yuji Mizukami, Seiyuu Suzuki, Masayoshi Uraoka, Naozumi Shibata, Sanae Nakamura, Satoshi Imamine, Hidehiro Murakami, Katsuhisa Ohashi, Masamoto Torisu, Makoto Yano, Aki Hasebe, Harumi Yano, Masato Murakami, Eiji Takeshita, Yoshio Ikeda, Yoichi Hiasa

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Serum globulin is an inflammation marker. To date, no evidence regarding the association between serum globulin and disease activity in patients with ulcerative colitis has been reported.

Aims

We evaluated the association between serum globulin and endoscopic activity in patients with ulcerative colitis.

Methods

Serum globulin was divided into tertiles based on the distribution of study subjects (low globulin, ≤ 2.7 g/dl (reference); moderate globulin, 2.7–3.1 g/dl; and high globulin, > 3.1 g/dl). A single endoscopic specialist evaluated the endoscopic findings, and mucosal healing was based on Mayo endoscopic subscore.

Results

A total of 277 patients with ulcerative colitis were included in the study. Serum globulin was independently positively associated with diminished or absent vascular markings [moderate: adjusted odds ratio (OR) 3.70 (95% confidence interval, CI: 1.82–7.88) and high: adjusted OR 2.40 (95%CI: 1.20–4.94), p for trend = 0.005]. A similar positive association between globulin and erosion was found [high: adjusted OR 2.00 (95%CI: 1.05–3.86)]. Serum globulin was independently inversely associated with mucosal healing [moderate: adjusted OR 0.37 (95%CI: 0.18–0.73) and high: adjusted OR 0.31 (95%CI: 0.14–0.64), p for trend = 0.001] and adjusted partial mucosal healing [moderate: OR 0.51 (95%CI: 0.26–0.98), p for trend = 0.048]. The inverse association between globulin and mucosal healing was significant in the low but not the high C-reactive protein group.

Conclusions

In patients with ulcerative colitis, serum globulin was significantly positively associated with endoscopic activity, and was significantly inversely associated with mucosal healing, especially in the low C-reactive protein group.
Literatur
1.
Zurück zum Zitat Langholz E, Munkholm P, Davidsen M et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3–11CrossRef Langholz E, Munkholm P, Davidsen M et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3–11CrossRef
2.
Zurück zum Zitat Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011;141:1194–1201CrossRef Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011;141:1194–1201CrossRef
3.
Zurück zum Zitat Frøslie KF, Jahnsen J, Moum BA et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412–422CrossRef Frøslie KF, Jahnsen J, Moum BA et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412–422CrossRef
4.
Zurück zum Zitat Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis 2010;16:338–346CrossRef Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis 2010;16:338–346CrossRef
5.
Zurück zum Zitat Peyrin-Biroulet L, Ferrante M, Magro F et al. Results from the 2nd scientific workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011;5:477–483CrossRef Peyrin-Biroulet L, Ferrante M, Magro F et al. Results from the 2nd scientific workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011;5:477–483CrossRef
6.
Zurück zum Zitat Sandborn WJ, Panés J, Zhang H et al. Correlation between concentrations of fecal calprotectin and outcomes of patients with ulcerative colitis in a phase 2 trial. Gastroenterology 2016;150:96–102CrossRef Sandborn WJ, Panés J, Zhang H et al. Correlation between concentrations of fecal calprotectin and outcomes of patients with ulcerative colitis in a phase 2 trial. Gastroenterology 2016;150:96–102CrossRef
7.
Zurück zum Zitat Shah SC, Colombel JF, Sands BE et al. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016;14:1245–1255CrossRef Shah SC, Colombel JF, Sands BE et al. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016;14:1245–1255CrossRef
8.
Zurück zum Zitat Colombel JF, D’Hasens G, Lee WJ et al. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis 2020;14:254–266CrossRef Colombel JF, D’Hasens G, Lee WJ et al. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis 2020;14:254–266CrossRef
9.
Zurück zum Zitat H. Kenneth Walker. Clinical Methods: The History, Physical and Laboratory Examinations. 3rd ed. Butterworth-Heinemann, London, 1990; 497–499 H. Kenneth Walker. Clinical Methods: The History, Physical and Laboratory Examinations. 3rd ed. Butterworth-Heinemann, London, 1990; 497–499
10.
Zurück zum Zitat Feinstein AR, Petersdorf RG. The clinical significance of hyperglobulinemia. Ann Intern Med 1956;44:899–924CrossRef Feinstein AR, Petersdorf RG. The clinical significance of hyperglobulinemia. Ann Intern Med 1956;44:899–924CrossRef
11.
Zurück zum Zitat Hodgson HJ, Jewell DP. The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels. Am J Dig Dis 1978;23:123–128CrossRef Hodgson HJ, Jewell DP. The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels. Am J Dig Dis 1978;23:123–128CrossRef
12.
Zurück zum Zitat Gryboski JD, Spiro HM. Prognosis in children with Crohn’s disease. Gastroenterology 1978;74:807–817CrossRef Gryboski JD, Spiro HM. Prognosis in children with Crohn’s disease. Gastroenterology 1978;74:807–817CrossRef
13.
Zurück zum Zitat Ordás L, Eckmann L, Talamini M et al. Ulcerative colitis. Lancet 2012;380:1606–1619CrossRef Ordás L, Eckmann L, Talamini M et al. Ulcerative colitis. Lancet 2012;380:1606–1619CrossRef
14.
Zurück zum Zitat Scheller J, Garbers C, Rose-John S. Interleukin-6 from basic biology to selective blockade of proinflammatory activities. Semin Immunol 2013;26:2–12CrossRef Scheller J, Garbers C, Rose-John S. Interleukin-6 from basic biology to selective blockade of proinflammatory activities. Semin Immunol 2013;26:2–12CrossRef
15.
Zurück zum Zitat Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res 2018;16:26–42CrossRef Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res 2018;16:26–42CrossRef
Metadaten
Titel
Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis
verfasst von
Kana Shiraishi
Shinya Furukawa
Sen Yagi
Kenichirou Mori
Tomoyuki Ninomiya
Keitarou Kawasaki
Yuji Mizukami
Seiyuu Suzuki
Masayoshi Uraoka
Naozumi Shibata
Sanae Nakamura
Satoshi Imamine
Hidehiro Murakami
Katsuhisa Ohashi
Masamoto Torisu
Makoto Yano
Aki Hasebe
Harumi Yano
Masato Murakami
Eiji Takeshita
Yoshio Ikeda
Yoichi Hiasa
Publikationsdatum
04.02.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06834-5

Weitere Artikel der Ausgabe 1/2022

Digestive Diseases and Sciences 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.